Skip to content

Veradermics MANE Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Argan logo
ArganAGX
$22.65M+131%
McCormick & Company, Incorporated logo
McCormick & Company, IncorporatedMKC
$294.3M-0.9%
Exelixis logo
ExelixisEXEL
$282.87M+26.5%
Texas Pacific Land logo
Texas Pacific LandTPL
$3.4M
Curtiss-Wright logo
Curtiss-WrightCW
$35.01M-9.6%
PPG Industries logo
PPG IndustriesPPG
$619M+1.6%

Other financials

Income statement

See full
Operating income-$29.9M-131%
Net income-$27.2M-120%
EPS (diluted)-$1.32+93.3%

Balance sheet

See full
Cash & equivalents$168.4M+419%
Total debt$4.0K
Total equity$390.6M+744%
Total assets$397.4M

Cash flow

See full
Operating cash flow-$21.2M-59.0%
CapEx--100%
Free cash flow-$21.2M-58.7%

Valuation

See full
Market cap$3.92B

Returns & leverage

See full
Return on equity-28.7%
Current ratio59.1×

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Veradermics ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veradermics 's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veradermics 's operating lease ROU assets?
Veradermics (MANE) reported operating lease ROU assets of $103K in Q4 2025.
What does operating lease ROU assets mean?
The value of the company's right to use leased assets like offices or labs over the lease term.
How do you interpret operating lease ROU assets?
An increase indicates expansion of leased facilities, while a decrease suggests lease expirations or downsizing.
How does operating lease ROU assets compare across companies?
Standard for all companies with significant real estate footprints; peers in biotech often have significant ROU assets for lab space.